2w
Did you know? COPD is characterized by persistent airflow limitation and chronic respiratory symptoms that can significantly impair daily functioning and quality of life. Optimizing symptom control and reducing exacerbation risk remain key goals of long-term disease management.
What factors most influence your selection of maintenance therapy in patients with symptomatic COPD?
What factors most influence your selection of maintenance therapy in patients with symptomatic COPD?
-
JOEL WASHINSKY2wSeverity and frequency of exacerbations.
-
Amber Cook2wQuality of life factors that can be improved (dyspnea at baseline and with exertion, ER visits, admissions for exacerbations, etc).
-
Leon Ronen1moThey continue to have symptoms requiring office visits, hospitalization or visits to urgent care or ER. They are unhappy and desire further intervention.
-
Kevin Glass1moOngoing symptoms on current therapy, exacerbations and hospitalizations lead to early triple therapy. Insurance coverage and difficulty using the inhaler device lead to considering nebulized medication. Ongoing symptoms on triple therapy leads to considering Ohtuvayre or ordering eosinophil counts.
-
Swati Desai1moSeverity and frequency of exacerbations suggest need for aggressive therapy
-
SHABNAM SACHDEVA1moFrequency of exacerbations and hospitalizations guides the need for triple terapy and biologics
-
Kristina Cipparrone1moInsurance coverage, patient compliance, ability for patient to maneuver the device
-
SACHINKUMAR PANCHAL1moSeverity is typically assessed using a COPD assessment test score or MMRC dyspnea scales. Patient with high symptoms level are often initiated on a dual LABA + LAMA
-
BRETT NILE1mocompliance, more compliant patient get inhaler and the patients that can only handle once a day get Dry powder devices